Treatments aimed at patients diagnosed with amyloidosis fail to get to the root of the problem -- improving function of organs damaged by deposits of light-chain amyloid, researchers reported here at the annual meeting of the American Society of Hematology.
Trending:
Amyloidosis Treatments Miss the Heart of the Problem